Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1

Metastasis-suppressor genes, by definition, suppress metastasis without affecting tumorigenicity and, hence, present attractive targets as prognostic or therapeutic markers. BRMS1 (breast cancer metastasis suppressor) has recently been identified as a metastasis-suppressor gene for human breast cancer and melanoma. Expression of BRMS1 messenger RNA (mRNA) in multitissue including normal prostate, ovarian, testis, and colon has been detected by northern blot analysis. We hypothesize that the role of BRMS1 in tumor progression may not be limited to breast cancer and melanoma. We previously found that BRMS1 mRNA levels in primary ovarian epithelial carcinomas were significantly lower than that in normal ovarian and benign tumors (P < 0.05), and statistical analysis of BRMS1 mRNA levels revealed that BRMS1 mRNA levels were significantly higher in early tumor stages (I, II) compared with advanced tumor stages (III, IV) in which lymph node or distant metastases were present (P < 0.01). Our data showed that reduced BRMS1 mRNA seems to influence ovarian carcinoma metastatic ability. Therefore, we transfected BRMS1 plasmid into highly malignant ovarian carcinoma cell line, HO-8910PM, and examined cell biologic behaviors including proliferation, adhesion, invasion, and metastasis in vitro and in vivo. BRMS1 expression did not alter the proliferation of HO-8910PM cells in vitro and primary tumor formation in vivo. But, BRMS1 expression significantly suppressed the cell adhesion to extracellular matrix components and in vitro cell invasion in BRMS1-transfected HO-8910PM cells compared to parental HO-8910PM and vector-only transfectants (HO-8910PM-vect). Furthermore, motility of BRMS1 transfectants was inhibited. lung colony formation of intravenously injected BRMS1 transfectants in nude mice was significantly reduced. Also, BRMS1 transfectants form significantly less metastatic to organs of peritoneal cavity in orthotopically implanted ovarian tumor nude models. We further discovered that BRMS1 expression did downregulate expression of an actin-bundling protein associated with cell motility -fascin, which perhaps is the mechanism underlying BRMS1 suppression of metastasis. These data suggested that in addition to its already described role in breast cancer and melanoma, BRMS1 functions as a metastasis-suppressor gene in ovarian carcinoma by modifying several metastatic-associated phenotypes, offering a new target for therapeutic intervention.     

角膜重度碱烧伤羊膜移植治疗实验研究

目的 探讨羊膜移植治疗兔眼重度碱烧伤的机理，为其临床应用提供基础理论依据。方法建立兔眼角膜碱烧伤模型，分别以生理盐水、氯霉素眼药水、氯霉素眼药水和0．1％地塞米松及羊膜移植进行治疗，取伤后1d，3d，7d，14d房水检测TNF-α、IL—1。结果各时段氯霉素眼药水和0．1％地塞米松组和羊膜移植治疗组与生理盐水组和氯霉素眼药水组TNF—α、IL—1的活性和含量明显受到抑制。结论抑制TNF—α和IL—1的生物合成和释放可能是羊膜移植治疗角膜碱烧伤的机理之一。     

植入式心律转复除颤患者的护理及随访

目的总结植入式心律转复除颤器(ICD)安置术的护理。方法2001年7月~2004年6月给予13例ICD患者进行了护理及随访。结果术后有2例患者出现心律失常“风暴”,经处理后未再出现心室颤动。随访患者1~4年,均存活,未发生晕厥等并发症。结论术前重视患者的心理护理,术后密切观察病情,积极预防心律失常“风暴”,并做好ICD健康教育,是ICD手术成功的重要护理措施。     

随意皮瓣术后内皮素变化及其受体阻滞剂对皮瓣微循环的影响

目的:探讨随意皮瓣术后内皮素(ET)水平变化及内皮素受体阻滞剂BQ-123(A选择性)对随意皮瓣微循环的影响.方法:SD大鼠背部肉膜下形成随意皮瓣,测皮瓣组织ET的变化趋势.分用药组(BQ-123组)和对照组(生理盐水组),测皮瓣存活率,取材进行HE染色光镜检查,使用激光多谱勒血流仪测量皮瓣血运情况.结果:皮瓣术后ET水平急剧上升,24 h内维持较高水平.术后第10天,用药组皮瓣的存活率显著高于对照组.HE染色光镜检查见用药组组织损害较对照组小.激光多谱勒测量发现用药组较对照组激光多谱勒血流量相对值(LDF)下降少,恢复快.结论:皮瓣术后ET水平急剧上升,并维持较高水平,内皮素受体阻滞剂BQ-123(ETA高度选择性)可以阻断ET作用途径,有利于改善皮瓣微循环.     

ALTERATION OF CHOLESTEROL SULFATE IN HUMAN SERA DURING THE COURSE OF PREGNANCY

Objective To determine the concentrations of cholesterol sulfate ( CS) in human sera and pla-cental villi during the course of pregnancy. And to analyze its inhibitory activity on thrombin and further characterize the functional significance of CS. Methods The concentrations of CS were determined by thin-layer chromatog-raphy (TLC) on 60 cases of normal pregnant women and 30 cases of normal placental villi. The effect of CS in human sera on the activity of thrombin was analyzed. Results The concentrations of CS in human sera gradually increased from the first to third trimester of gestation with a correlation coefficient of 0. 69, and a correlation between the concentration of CS and weeks of gestation (P <0. 01). CS was also contained in the placental villi, and its concentrations at the second and third trimester of gestations were 4. 7 and 6. 2-fold of that at the first trimester of gestation. CS inhibited the activity of thrombin. Conclusion Placental CS is one of the sources of CS in the serum , pr     

脑动脉瘤破裂伴发急性硬膜下血肿的诊治

目的 探讨脑动脉瘤(AN)破裂所致的急性硬膜下血肿(ASDH)的临床、影像学特点和诊治方案。方法 回顾288例破裂AN，发现10例伴有ASDH。Huni Hess分级，Ⅱ级3人，Ⅲ级1人，Ⅳ级3人，Ⅴ级3人，均经CTA诊断为AN破裂，除2例外均被脑血管造影或手术所证实。保守治疗2例，血肿清除加AN夹闭术4例，电解脱弹簧圈(GDC)栓塞后加血肿清除2例，栓塞加脑室外引流1例，单纯栓塞l例。结果 疗效优者2例，中残者l例，7例死亡。结论 AN性ASDH的预后极差，同术前分级相关；CTA检查后立即行血肿清除加动脉瘤夹闭有助于提高预后，合适患者可联合栓塞和血肿清除术。     

跨矢状窦脑膜瘤术中矢状窦的处理

目的总结跨矢状窦脑膜瘤术中矢状窦的处理方法.方法对26例跨矢状窦脑膜瘤及受累矢状窦进行切除,依具体情况重建或不重建矢状窦.结果该组病人无手术死亡,手术后均未加重原有神经功能障碍,无脑血液回流障碍,7例重建矢状窦者未发现有矢状窦内血栓形成.结论矢状窦旁脑膜瘤的治疗除肿瘤切除外,对受累上矢状窦处理是否彻底对预防术后复发是至关重要的.对受累矢状窦应按具体情况按一定的原则进行积极处理.     

子宫黏膜下肌瘤行膨宫泵等离子电切术的手术配合

目的 探讨子宫黏膜下肌瘤行膨宫泵和等离子电切术的配合要点。方法 对30例子宫黏膜下肌摘患者使用膨宫泵和等离子电切手术。结果 30例手术顺利．均1次完成切除，平均手术时间40min，平均住院5d出院,无1例发生并发症。结论 术前心理护理、设备准备，术中正确摆放体位、熟练应用专科器械是护理配合的要点。     

生物胶复合物加解剖钢板内固定治疗胫骨平台骨折

目的探讨生物胶复合物加解剖钢板内固定治疗胫骨平台骨折的临床效果。方法采用切开复位、生物胶复合物植骨加解剖型支撑钢板内固定治疗胫骨平台骨折28例,受伤至手术时间5～10d,植入复合物量为3～8g。结果所有患者均获随访,随访6～24个月,全部骨折均获得临床愈合,未见关节面下陷,生物胶复合物中羟基磷灰石未见移动及吸收,治疗效果参照M echant评分标准,优13例,良11例,可3例,差1例,总优良率达85.3%。结论生物胶复合物加解剖钢板内固定治疗胫骨平台骨折的临床效果良好。生物胶复合物具有较强的成骨能力,可修复骨缺损。     

颈动脉分叉血液动力状态的计算流体力学初步研究

目的应用计算流体力学（CFD）方法结合血管影像显示在体颈动脉分叉的血流动力状态.方法选取1例志愿者,采用Siemens多层螺旋CT机行左侧颈动脉CT血管成像检查（CTA）,扫描所得原始图像经计算机后处理后,用CFD方法计算并显示血液动力学各项指标.结果（1）该血管血液流率均值范围为0.04～0.36 m/s,颈外和颈内动脉的内侧壁（均以分叉顶点为参照）可见一高血流速区,球部可见较大片低血流速区;颈动脉分叉及颈内、外动脉近端均可见血液涡流与回流.（2）血液绝对压、静态压和动态压的均值范围分别为100 266.70～101 615.90 Pa、-10 58.34～290.88 Pa、6.12～553.25 Pa;（3）管壁切应力均值范围为0.59～5.35 Pa,在颈动脉球部及颈内动脉后壁显示大范围的低切应力区,最低约为0.25 Pa,颈外动脉前外侧壁存在一小范围低切应力区.结论CFD方法结合血管影像能计算并显示在体颈动脉分叉的个体化血液动力学指标.